The short answer
Sodium citrate may lower lithium levels when used in amounts that act as an alkalinizing treatment. The concern is increased urinary lithium removal, and its size has not been measured for every product.
What this answer covers
Oral sodium citrate; supporting label combines sodium citrate dihydrate with citric acid. Food-additive exposure is not automatically medicinal alkali exposure.
- Supplement or preparation
- Sodium citrate
- Medication ingredient
- lithium citrate
A kidney-clearance concern
Sodium citrate can provide an alkaline load. The lithium solution label warns that alkalinizing agents can increase urinary lithium excretion and lower lithium concentrations. This supports a conditional concern about blood levels rather than a demonstrated reduction in gut absorption.
How directly this has been studied
The supporting sodium citrate label explains the product’s alkalinizing action, but does not report a lithium citrate coadministration experiment. The amount, formulation, kidney function and reason for treatment matter. A warning about medicinal alkali use cannot quantify every supplement or incidental food exposure.
Spacing does not resolve the mechanism
No reviewed source establishes that taking these products a few hours apart prevents the renal interaction. Nor does the lithium label require that every necessary alkalinizing treatment be abandoned. A clinician can assess whether a level check or treatment adjustment is appropriate.
Plan changes with the prescriber
Give the treating team the exact product and daily amount before starting, stopping or substantially changing it. If it is prescribed for a kidney or acid-base condition, coordinate changes with that clinician. Do not adjust lithium yourself to compensate for a possible interaction.
Evidence and practical considerations
Absorption & effectiveness
Conditional alkali-class extrapolation from sodium citrate combination label; no exact standalone citrate dose-response or absorption study.
- Exact scope
- Oral sodium citrate; supporting label combines sodium citrate dihydrate with citric acid. Food-additive exposure is not automatically medicinal alkali exposure. with Lithium citrate oral solution, exact RxCUI 52105; current NLM IN. Carbonate evidence is indirect through lithium ion where stated.
- Medication form and route
- oral lithium citrate; oral supplement
What remains uncertain
- Source-specific identity, preparation and endpoint limitations apply; no unstudied dose conversion.
Factors that may matter: Exact preparation; Amount and changes in use; Kidney function; Other medicines.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed lithium oral solution.
Lithium is eliminated mainly in urine. Sodium depletion can reduce clearance and raise levels; xanthines and alkalinizing agents can increase urinary excretion and lower levels. Serotonergic agents, explicitly including St John’s wort, increase serotonin-syndrome risk.
How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.
Lithium active-moiety bridge supports renal pharmacology across salts but not identical formulation kinetics, dose equivalence for self-use or quantified effects of every herb.
Source 2: manufacturer product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Users of the specified oral preparation.
Sodium citrate is metabolized to sodium bicarbonate; the formulation acts as a systemic alkalinizer.
How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.
Manufacturer label for an unapproved-drug-other listing, not FDA approval. Combination formulation is indirect for standalone sodium citrate; no lithium coadministration experiment.
Research assessment: · Open full citations ↗
Timing & monitoring
No universal separation interval or all-product avoidance established by these sources; review changes and monitoring.
- Exact scope
- Oral sodium citrate; supporting label combines sodium citrate dihydrate with citric acid. Food-additive exposure is not automatically medicinal alkali exposure. with Lithium citrate oral solution, exact RxCUI 52105; current NLM IN. Carbonate evidence is indirect through lithium ion where stated.
- Medication form and route
- oral lithium citrate; oral supplement
What remains uncertain
- Source-specific identity, preparation and endpoint limitations apply; no unstudied dose conversion.
Factors that may matter: Exact preparation; Amount and changes in use; Kidney function; Other medicines.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed lithium oral solution.
Lithium is eliminated mainly in urine. Sodium depletion can reduce clearance and raise levels; xanthines and alkalinizing agents can increase urinary excretion and lower levels. Serotonergic agents, explicitly including St John’s wort, increase serotonin-syndrome risk.
How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.
Lithium active-moiety bridge supports renal pharmacology across salts but not identical formulation kinetics, dose equivalence for self-use or quantified effects of every herb.
Source 2: manufacturer product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Users of the specified oral preparation.
Sodium citrate is metabolized to sodium bicarbonate; the formulation acts as a systemic alkalinizer.
How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.
Manufacturer label for an unapproved-drug-other listing, not FDA approval. Combination formulation is indirect for standalone sodium citrate; no lithium coadministration experiment.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact-pair article preserving salt, botanical and evidence limitations. | |
| Research summary published |
Article revision: 5298fa9121160034
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.